Your browser doesn't support javascript.
loading
Improving preparedness to respond to cross-border hepatitis A outbreaks in the European Union/European Economic Area: towards comparable sequencing of hepatitis A virus.
Enkirch, Theresa; Severi, Ettore; Vennema, Harry; Thornton, Lelia; Dean, Jonathan; Borg, Maria-Louise; Ciccaglione, Anna Rita; Bruni, Roberto; Christova, Iva; Ngui, Siew Lin; Balogun, Koye; Nemecek, Vratislav; Kontio, Mia; Takács, Mária; Hettmann, Andrea; Korotinska, Rita; Löve, Arthur; Avellón, Ana; Muñoz-Chimeno, Milagros; de Sousa, Rita; Janta, Denisa; Epstein, Jevgenia; Klamer, Sofieke; Suin, Vanessa; Aberle, Stephan W; Holzmann, Heidemarie; Mellou, Kassiani; Ederth, Josefine Lundberg; Sundqvist, Lena; Roque-Afonso, Anne-Marie; Filipovic, Sanja Kurecic; Poljak, Mario; Vold, Line; Stene-Johansen, Kathrine; Midgley, Sofie; Fischer, Thea Kølsen; Faber, Mirko; Wenzel, Jürgen J; Takkinen, Johanna; Leitmeyer, Katrin.
Afiliação
  • Enkirch T; Public Health Agency of Sweden, Solna, Sweden.
  • Severi E; European Programme for Public Health Microbiology Training (EUPHEM), European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
  • Vennema H; European Centre for Disease Prevention and Control (ECDC), Solna, Sweden.
  • Thornton L; Karolinska Institutet, Stockholm, Sweden.
  • Dean J; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
  • Borg ML; HSE - Health Protection Surveillance Centre, Dublin, Ireland.
  • Ciccaglione AR; National Virus Reference Laboratory, Dublin, Ireland.
  • Bruni R; Ministry of Health, Msida, Malta.
  • Christova I; National Institute of Health, Rome, Italy.
  • Ngui SL; National Institute of Health, Rome, Italy.
  • Balogun K; National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria.
  • Nemecek V; Public Health England (PHE), London, United Kingdom.
  • Kontio M; Public Health England (PHE), London, United Kingdom.
  • Takács M; National Institute of Public Health, Prague, Czech Republic.
  • Hettmann A; National Institute for Health and Welfare (THL), Helsinki, Finland.
  • Korotinska R; National Public Health Institute, Budapest, Hungary.
  • Löve A; National Public Health Institute, Budapest, Hungary.
  • Avellón A; Centre for Disease Prevention and Control, Riga, Latvia.
  • Muñoz-Chimeno M; Landspitali- National University Hospital, Reykjavik, Iceland.
  • de Sousa R; Carlos III Institute of Health, Madrid, Spain.
  • Janta D; Carlos III Institute of Health, Madrid, Spain.
  • Epstein J; National Institute of Health Dr. Ricardo Jorge (INSA), Lisbon, Portugal.
  • Klamer S; National Institute of Public Health, Bucharest, Romania.
  • Suin V; Health Board, Tallinn, Estonia.
  • Aberle SW; Scientific Institute of Public Health, Brussels, Belgium.
  • Holzmann H; Sciensano, Directorate Infectious diseases in humans, Brussels, Belgium.
  • Mellou K; Center for Virology, Medical University of Vienna, Vienna, Austria.
  • Ederth JL; Center for Virology, Medical University of Vienna, Vienna, Austria.
  • Sundqvist L; Hellenic Centre for Disease Control and Prevention, Athens, Greece.
  • Roque-Afonso AM; Public Health Agency of Sweden, Solna, Sweden.
  • Filipovic SK; Public Health Agency of Sweden, Solna, Sweden.
  • Poljak M; National Reference Centre for Hepatitis A, Villejuif, France.
  • Vold L; Croatian Institute of Public Health, Zagreb, Croatia.
  • Stene-Johansen K; Institute of Microbiology and Immunology, Ljubljana, Slovenia.
  • Midgley S; Norwegian institute of Public Health, Oslo, Norway.
  • Fischer TK; Norwegian institute of Public Health, Oslo, Norway.
  • Faber M; Statens Serum Institut (SSI), Copenhagen, Denmark.
  • Wenzel JJ; Statens Serum Institut (SSI), Copenhagen, Denmark.
  • Takkinen J; Department of Infectious Diseases and Global Health, University of Southern Denmark, Odense, Denmark.
  • Leitmeyer K; Robert Koch Institute (RKI), Berlin, Germany.
Euro Surveill ; 24(28)2019 Jul.
Article em En | MEDLINE | ID: mdl-31311618
IntroductionSequence-based typing of hepatitis A virus (HAV) is important for outbreak detection, investigation and surveillance. In 2013, sequencing was central to resolving a large European Union (EU)-wide outbreak related to frozen berries. However, as the sequenced HAV genome regions were only partly comparable between countries, results were not always conclusive.AimThe objective was to gather information on HAV surveillance and sequencing in EU/European Economic Area (EEA) countries to find ways to harmonise their procedures, for improvement of cross-border outbreak responses.MethodsIn 2014, the European Centre for Disease Prevention and Control (ECDC) conducted a survey on HAV surveillance practices in EU/EEA countries. The survey enquired whether a referral system for confirming primary diagnostics of hepatitis A existed as well as a central collection/storage of hepatitis A cases' samples for typing. Questions on HAV sequencing procedures were also asked. Based on the results, an expert consultation proposed harmonised procedures for cross-border outbreak response, in particular regarding sequencing. In 2016, a follow-up survey assessed uptake of suggested methods.ResultsOf 31 EU/EEA countries, 23 (2014) and 27 (2016) participated. Numbers of countries with central collection and storage of HAV positive samples and of those performing sequencing increased from 12 to 15 and 12 to 14 respectively in 2016, with all countries typing an overlapping fragment of 218 nt. However, variation existed in the sequenced genomic regions and their lengths.ConclusionsWhile HAV sequences in EU/EEA countries are comparable for surveillance, collaboration in sharing and comparing these can be further strengthened.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 3_ND Problema de saúde: 1_surtos_doencas_emergencias / 2_enfermedades_transmissibles / 3_zoonosis Assunto principal: Vigilância da População / Surtos de Doenças / Vírus da Hepatite A / Tipagem Molecular / Sequenciamento Completo do Genoma / Hepatite A Tipo de estudo: Health_economic_evaluation / Screening_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Euro Surveill Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 3_ND Problema de saúde: 1_surtos_doencas_emergencias / 2_enfermedades_transmissibles / 3_zoonosis Assunto principal: Vigilância da População / Surtos de Doenças / Vírus da Hepatite A / Tipagem Molecular / Sequenciamento Completo do Genoma / Hepatite A Tipo de estudo: Health_economic_evaluation / Screening_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Euro Surveill Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Suécia
...